Drug intelligence / Profile preview

rhododendron molle extract

Development stage
Preclinical
Administration
Oral, Topical
01

Overview

Rhododendron molle extract is derived from the leaves, roots, flowers, or fruits of the plant *Rhododendron molle* G. Don, a traditional Chinese medicinal herb. The extract contains a rich profile of bioactive compounds, including diterpenoids (e.g., rhodojaponin III), triterpenoids, flavonoids, and lignans. It has been recognized for its **anti-inflammatory**, **analgesic**, **antioxidant**, and **anticancer** effects, as well as for antibacterial and insecticidal activities[1][2][5]. Pharmaceutically, R. molle extract inhibits pro-inflammatory cytokines (such as TNF-α, IL-1β, IL-6), suppresses enzymes like COX-2 and iNOS, and can induce apoptosis in cancer cells and inhibit tumor cell migration[1][4][5][7]. Its primary mechanisms involve modulation of inflammatory pathways and suppression of cell proliferation. The extract has shown efficacy in preclinical models for rheumatic diseases (notably rheumatoid arthritis), hypertension, chronic bronchitis, and as an adjunct in cancer treatment, particularly against colorectal cancer cells[1][3][4]. However, the plant and its extracts contain toxic diterpenoids and should be used cautiously[1][2]. While widely used in traditional and experimental medicine, it is not an approved pharmaceutical drug in major regulatory jurisdictions.

Other names
Rhododendron molle G. Don extractRLERhododendron molle leaf extract
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)NOS1 (nNOS)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on rhododendron molle extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rhododendron molle extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call